CEL-SCI Corporation (CVM)
NYSEAMERICAN: CVM · Real-Time Price · USD
3.940
-0.060 (-1.50%)
Mar 6, 2026, 4:00 PM EST - Market closed
CEL-SCI Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
44
Market Cap
31.89M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Celularity | 40.58M |
| Pluri | 1.34M |
| Werewolf Therapeutics | 1.14M |
| RenovoRx | 928.00K |
| ABVC BioPharma | 797.92K |
| Outlook Therapeutics | 205.70K |
CVM News
- 17 days ago - CEL-SCI Reports Fiscal First Quarter 2026 Results - Business Wire
- 2 months ago - CEL-SCI Reports Fiscal 2025 Results - Business Wire
- 4 months ago - CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025 - Newsfile Corp
- 5 months ago - CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference - Newsfile Corp
- 6 months ago - CEL-SCI Announces Closing of $10 Million Public Offering - Business Wire
- 6 months ago - CEL-SCI Announces Pricing of $10 Million Public Offering - Business Wire
- 6 months ago - CEL-SCI Announces Proposed Public Offering - Business Wire
- 7 months ago - CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results - Business Wire